Grifols SA: 3‑Year Stock Gains, Plasma‑Fractionation Growth & Market Outlook
Grifols SA stock shows modest 3‑year gains as plasma‑derived markets grow; €10.15 share price, €6.65 bn cap, and a 10.3 % CAGR for plasma fractionation highlight future upside.
3 minutes to read